DIAMOND-1: A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1) (clinicaltrials.gov) - May 6, 2026 - P2/3 | N=552 | Completed | Sponsor: Oculis | Active, not recruiting ➔ Completed
Trial completion • Diabetic Macular Edema • Ophthalmology
|